ADL Bionatur Solutions announced the earnings results for the first six months of 2019. For this period, the company reported revenues of the first half of 2019 amounted to EUR 22.5 million against EUR 9.5 million reflecting a 138% growth compared to the same period last year. EBITDA turned positive with EUR 0.595 million compared to a loss of EUR 5.9 million for the same period of 2018.

The company also provided its full year guidance of revenues above EUR 50 million and the first overall positive full year EBITDA result.